Fulcrum Therapeutics Inc. is a biopharmaceutical company that uses its proprietary chemistry-based platform to develop small molecule drugs. The company focuses on discovering and developing therapies for rare genetic diseases. With a strong pipeline of potential treatments, Fulcrum Therapeutics aims to address unmet medical needs and improve the lives of patients.
Notification